Matt Roache | Director of Investor Relations |
Tom McCourt | CEO |
Mike Shetzline | Chief Medical Officer |
Sravan Emany | Chief Financial Officer |
Tim Chiang | Capital One |
Boris Peaker | Cowen |
Jacob Hughes | Wells Fargo Securities |
Good day, and welcome to the Ironwood Pharmaceuticals Q1 2023 Investor Update Conference Call. Today's call is being recorded [Operator Instructions].
I will now turn the call over to Matt Roache, Director of Investor Relations. Please go ahead.
Thank you, Angela.